Zobrazeno 1 - 10
of 27 358
pro vyhledávání: '"LIM domain"'
Autor:
Svaguša T; Department of Cardiovascular Diseases, Dubrava University Hospital, Zagreb, Croatia., Sedlić F; Department of Pathophysiology, University of Zagreb School of Medicine, Zagreb, Croatia., Županić S; Department of Neurology, Dubrava University Hospital, Zagreb, Croatia., Manola Š; Department of Cardiovascular Diseases, Dubrava University Hospital, Zagreb, Croatia., Bakoš M; Department of Pediatrics, University Hospital Centre Zagreb, Zagreb, Croatia., Mirošević V; Department of Pathophysiology, University of Zagreb School of Medicine, Zagreb, Croatia., Livun A; Department of Scientific Research and Translational Medicine, Dubrava University Hospital, Zagreb, Croatia.
Publikováno v:
Clinical genetics [Clin Genet] 2024 Nov; Vol. 106 (5), pp. 659-660. Date of Electronic Publication: 2024 Jul 11.
Autor:
Schelker RC; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany. roland.schelker@ukr.de.; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. roland.schelker@ukr.de.; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA. roland.schelker@ukr.de.; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany. roland.schelker@ukr.de., Fioravanti J; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany.; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Mastrogiovanni F; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany., Baldwin JG; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany.; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Rana N; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany.; Next Generation Sequencing Core, Leibniz Institute for Immunotherapy, Regensburg, Germany., Li P; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Chen P; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Vadász T; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany., Spolski R; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Heuser-Loy C; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany., Slavkovic-Lukic D; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany., Noronha P; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany., Damiano G; Immuno-Biotherapy of Melanoma and Solid Tumors Unit, Division of Experimental Oncology, IRCCS Scientific Institute San Raffaele, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Raccosta L; Immuno-Biotherapy of Melanoma and Solid Tumors Unit, Division of Experimental Oncology, IRCCS Scientific Institute San Raffaele, Milan, Italy., Maggioni D; Immuno-Biotherapy of Melanoma and Solid Tumors Unit, Division of Experimental Oncology, IRCCS Scientific Institute San Raffaele, Milan, Italy., Pullugula S; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Lin JX; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Oh J; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Grandinetti P; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Lecce M; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany., Hesse L; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany.; University of Regensburg, Regensburg, Germany., Kocks E; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany.; University of Regensburg, Regensburg, Germany., Martín-Santos A; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany., Gebhard C; Next Generation Sequencing Core, Leibniz Institute for Immunotherapy, Regensburg, Germany., Telford WG; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Ji Y; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Restifo NP; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Russo V; Immuno-Biotherapy of Melanoma and Solid Tumors Unit, Division of Experimental Oncology, IRCCS Scientific Institute San Raffaele, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Rehli M; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Next Generation Sequencing Core, Leibniz Institute for Immunotherapy, Regensburg, Germany., Herr W; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; National Center for Tumor Diseases, WERA Site, Würzburg-Erlangen-Regensburg-Augsburg, Germany.; Center for Immunomedicine in Transplantation and Oncology, University Hospital Regensburg, Regensburg, Germany., Leonard WJ; Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA. leonardw@nhlbi.nih.gov., Gattinoni L; Division of Functional Immune Cell Modulation, Leibniz Institute for Immunotherapy, Regensburg, Germany. luca.gattinoni@lit.eu.; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. luca.gattinoni@lit.eu.; University of Regensburg, Regensburg, Germany. luca.gattinoni@lit.eu.; Center for Immunomedicine in Transplantation and Oncology, University Hospital Regensburg, Regensburg, Germany. luca.gattinoni@lit.eu.
Publikováno v:
Signal transduction and targeted therapy [Signal Transduct Target Ther] 2024 Aug 09; Vol. 9 (1), pp. 199. Date of Electronic Publication: 2024 Aug 09.
Autor:
Kim DS; Biomedical Engineering Department, University of California, Davis, Davis CA 95616, USA., Cheah JS; Biomedical Engineering Department, University of California, Davis, Davis CA 95616, USA., Lai TW; Biomedical Engineering Department, University of California, Davis, Davis CA 95616, USA., Zhao KX; Biomedical Engineering Department, University of California, Davis, Davis CA 95616, USA., Foust SR; Biomedical Engineering Department, University of California, Davis, Davis CA 95616, USA., Julie Lee YR; Department of Plant Biology, University of California, Davis, Davis CA 95616, USA., Lo SH; Department of Biochemistry and Molecular Medicine, University of California, Davis, Davis CA 95616 USA., Heinrich V; Biomedical Engineering Department, University of California, Davis, Davis CA 95616, USA., Yamada S; Biomedical Engineering Department, University of California, Davis, Davis CA 95616, USA. Electronic address: syamada@ucdavis.edu.
Publikováno v:
Cell reports [Cell Rep] 2024 Jul 23; Vol. 43 (7), pp. 114480. Date of Electronic Publication: 2024 Jul 13.
Autor:
Mezzacappa C; Department of Biology, Temple University, Philadelphia, PA, 19122, USA., Komiya Y; Department of Biology, Temple University, Philadelphia, PA, 19122, USA., Habas R; Department of Biology, Temple University, Philadelphia, PA, 19122, USA. Electronic address: habas@temple.edu.
Publikováno v:
Developmental biology [Dev Biol] 2024 Nov; Vol. 515, pp. 46-58. Date of Electronic Publication: 2024 Jul 03.
Autor:
Li, Sini1 (AUTHOR), Liu, Lihui1 (AUTHOR), Qu, Yan1 (AUTHOR), Yuan, Li1 (AUTHOR), Zhang, Xue1,2 (AUTHOR), Ma, Zixiao1 (AUTHOR), Bai, Hua1,2 (AUTHOR) baihua@cicams.ac.cn, Wang, Jie1,2 (AUTHOR) baihua@cicams.ac.cn
Publikováno v:
International Journal of Molecular Sciences. Mar2023, Vol. 24 Issue 5, p4524. 14p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tu Z; Department of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China., Wei W; Department of Dermatology, Anhui Medical University-Affiliated Provincial Hospital, Hefei, China., Zeng F; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China., Wang W; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China., Zhang Y; Department of Dermatology, WanNan Medical College, WuHu, China., Zhang Y; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China., Zhou F; Department of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei, China; Institute of Dermatology, Anhui Medical University, Hefei, China., Cai C; Department of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China., Zhang S; Department of Dermatology, Anhui Medical University-Affiliated Provincial Hospital, Hefei, China. Electronic address: zh_siping@126.com., Zhou H; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China; Institute of Dermatology, Anhui Medical University, Hefei, China; The Center for Scientific Research, Anhui Medical University, Hefei, China. Electronic address: haishengs@ahmu.edu.cn.
Publikováno v:
The American journal of pathology [Am J Pathol] 2024 May; Vol. 194 (5), pp. 708-720. Date of Electronic Publication: 2024 Feb 04.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lu Fang, Changjie Liu, Zong-zhe Jiang, Mengxiao Wang, Kang Geng, Yangkai Xu, Yujie Zhu, Yiwen Fu, Jing Xue, Wenxin Shan, Qi Zhang, Jie Chen, Jiahong Chen, Mingming Zhao, Yuxuan Guo, K. W. Michael Siu, Y. Eugene Chen, Yong Xu, Donghui Liu, Lemin Zheng
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 9, Iss 1, Pp 1-17 (2024)
Abstract Obesity is a global issue that warrants the identification of more effective therapeutic targets and a better understanding of the pivotal molecular pathogenesis. Annexin A1 (ANXA1) is known to inhibit phospholipase A2, exhibiting anti-infla
Externí odkaz:
https://doaj.org/article/8daebf7d4f754be28de48f719ff7a6d7
Autor:
Sala S; Department of Cell and Molecular Physiology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL 60153, USA., Oakes PW; Department of Cell and Molecular Physiology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL 60153, USA. Electronic address: poakes@luc.edu.
Publikováno v:
Current biology : CB [Curr Biol] 2023 May 08; Vol. 33 (9), pp. R339-R341.